Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys

被引:69
作者
Tian, BH
Gabelt, BT
Crosson, CE
Kaufman, PL
机构
[1] UNIV WISCONSIN,CTR CLIN SCI,DEPT OPHTHALMOL & VISUAL SCI,MADISON,WI 53792
[2] TEXAS TECH UNIV,HLTH SCI CTR,LUBBOCK,TX 79430
关键词
adenosine; agonists; antagonists; aqueous; facility; hypertension; hypotension; monkeys; ocular; outflow; pressure; receptors;
D O I
10.1006/exer.1997.0296
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The effects of single or multiple topical doses of the relatively selective A(1) adenosine receptor agonists (R)-phenylisopropyladenosine (R-PIA) and N-6-cyclohexyladenosine (CHA) on intraocular pressure (IOP), aqueous humor now (AHF) and outflow facility were investigated in ocular normotensive cynomolgus monkeys, IOP and AHF were determined, under ketamine anesthesia. by Goldmann applanation tonometry and fluorophotometry, respectively, Total outflow facility was determined by anterior chamber perfusion under pentobarbital anesthesia. A single unilateral topical application of R-PIA (20-250 mu g) or CHA (20-500 mu g) produced ocular hypertension (maximum rise = 4.9 or 3.5 mmHg) within 30 min, followed by ocular hypotension (maximum fall = 2.1 or 3.6 mmHg) from 2-6 hr. The relatively selective adenosine A(2) antagonist 3.7-dimethyl-1-propargylxanthine (DMPX, 320 mu g) inhibited the early hypertension, without influencing the hypotension. Neither 100 mu g R-PIA nor 500 mu g CHA clearly altered AHF. Total outflow facility was increased by 71% 3 hr after 100 mu g R-PIA, In conclusion, the early ocular hypertension produced by topical adenosine agonists in cynomolgus monkeys is associated with the activation of adenosine A(2) receptors, while the subsequent hypotension appears to be mediated by adenosine A(1) receptors and results primarily from increased outflow facility. (C) 1997 Academic Press Limited.
引用
收藏
页码:979 / 989
页数:11
相关论文
共 21 条
[1]  
BARANY EH, 1964, INVEST OPHTH VISUAL, V3, P135
[2]  
BARANY EH, 1965, STRUCTURE EYE, P223
[3]   THE POTENTIAL ROLE OF ADENOSINE IN REGULATING BLOOD-FLOW IN THE EYE [J].
BRAUNAGEL, SC ;
XIAO, JG ;
CHIOU, GCY .
JOURNAL OF OCULAR PHARMACOLOGY, 1988, 4 (01) :61-73
[4]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[5]  
CAMRAS CB, 1994, INVEST OPHTH VIS SCI, V35, P2052
[6]   OCULAR HYPOTENSIVE ACTIVITY OF THE ADENOSINE AGONIST (R)-PHENYLISOPROPYLADENOSINE IN RABBITS [J].
CROSSON, CE .
CURRENT EYE RESEARCH, 1992, 11 (05) :453-458
[7]  
Crosson CE, 1996, INVEST OPHTH VIS SCI, V37, P1833
[8]  
CROSSON CE, 1994, INVEST OPHTH VIS SCI, V35, P2052
[9]  
CROSSON CE, 1995, J PHARMACOL EXP THER, V273, P320
[10]   MODULATION OF INTRAOCULAR-PRESSURE BY ADENOSINE AGONISTS [J].
CROSSON, CE ;
GRAY, T .
JOURNAL OF OCULAR PHARMACOLOGY, 1994, 10 (01) :379-383